By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Intra-Cellular Therapies, Inc. 

3960 Broadway

New York  New York  10032  U.S.A.
Phone: 212-923-3344 Fax: 212-923-3388


SEARCH JOBS


Industry
Biotechnology






Company News
Intra-Cellular Therapies, Inc. Announces Phase III Clinical Development Program For The Treatment Of Depressive Episodes Associated With Bipolar Disorder (Bipolar Depression) 7/22/2015 7:11:34 AM
Intra-Cellular Therapies, Inc. Reports Initiation Of Randomization For ITI-007-302 Phase 3 Trial In Schizophrenia 6/23/2015 6:18:45 AM
Intra-Cellular Therapies, Inc. Reports Completion Of Enrollment With 450 Patients Randomized In The ITI-007-301 Phase III Clinical Trial For The Treatment Of Schizophrenia 6/15/2015 7:50:09 AM
Intra-Cellular Therapies, Inc. To Present At The Jefferies and Co. 2015 Global Healthcare Conference 5/26/2015 7:04:23 AM
Intra-Cellular Therapies, Inc. Announces Further Analyses Of The Phase II Clinical Trial Of ITI-007 In Schizophrenia At The 168th Annual Meeting Of The American Psychiatric Association 5/18/2015 7:29:24 AM
Intra-Cellular Therapies, Inc. To Present At The 2015 UBS Global Healthcare Conference 5/11/2015 10:38:06 AM
Intra-Cellular Therapies, Inc. To Present At The Bank of America (BAC) Merrill Lynch 2015 Health Care Conference 5/7/2015 12:34:42 PM
Intra-Cellular Therapies, Inc. Reports First Quarter 2015 Financial Results And Provides Corporate Update 4/30/2015 8:30:54 AM
Intra-Cellular Therapies, Inc. To Host First Quarter 2015 Financial Results Conference Call And Webcast 4/24/2015 7:37:31 AM
Intra-Cellular Therapies, Inc. Presents The ITI-007 Clinical Development Program At The 15th International Congress On Schizophrenia Research 3/31/2015 11:06:12 AM
1234567
//-->